companydata.dkcompanydata.dk

NOVOZYMES A/S: Financial statements 2015

CVR: 10007127

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 14,002,000,000 and a net result of DKK 2,825,000,000 compared with DKK 2,525,000,000 the year before. That is an increase of 12.4% compared with the year before. The profit margin was 20.2%. Equity in the 2015 report amounted to DKK 11,593,000,000. The solvency ratio was 65.2%.

Revenue
DKK 14,002,000,000
Gross Profit
DKK 8,129,000,000
Profit/Loss
DKK 2,825,000,000
Equity
DKK 11,593,000,000
Total Assets
DKK 17,791,000,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201514B8.1B2.8B11.6B-
201412.5B7.1B2.5B11.3B-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NOVOZYMES A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

NOVOZYMES A/S publishes interim reportNov 6, 2015

NOVOZYMES A/S has published its interim report for the period January 1, 2015 to September 30, 2015.

NOVOZYMES A/S publishes interim reportAug 28, 2015

NOVOZYMES A/S has published its interim report for the period January 1, 2015 to June 30, 2015.

NOVOZYMES A/S publishes interim reportApr 30, 2015

NOVOZYMES A/S has published its interim report for the period January 1, 2015 to March 31, 2015.

NOVOZYMES A/S: The 2014 annual report is outMar 29, 2015

NOVOZYMES A/S has published its annual report for 2014. Revenue came to DKK 12,459,000,000, and the net result was DKK 2,525,000,000.

Heinz-Jürgen Bertram joins the board of NOVOZYMES A/SFeb 25, 2015

As of February 25, 2015, Heinz-Jürgen Bertram has joined the board of directors of NOVOZYMES A/S.

About NOVOZYMES A/S

NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.

Source: annual report 2025, Danish Business Authority